Bharat Biotech to launch Covaxin by 2021 after approval

Pharmaceutical Company Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities. The vaccine will be developed in collaboration with Indian Council of Medical Research (ICMR).
The Executive Director of the company Sai Prasad said, “If we get all the approvals after establishing strong experimental evidence and data, and efficacy and safety data in our last stage of trials, we aim to launch the vaccine in Q2 of 2021”.
The company would proceed with the Phase 3 trial after receiving approval from the Drugs Controller General of India (DCGI).

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s